RFC
TEVA icon

Regions Financial Corp’s Teva Pharmaceuticals TEVA Stock Holding History

Regions Financial Corp’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,394
Closed -$129K – 854
2023
Q4 		$129K Buy
+12,394
New +$116K ﹤0.01% 800
2019
Q2 		– Sell
-6,809
Closed -$107K – 1628
2019
Q1 		$107K Buy
6,809
+14
+0.2% +$247 ﹤0.01% 959
2018
Q4 		$104K Sell
6,795
-340
-5% -$6.97K ﹤0.01% 947
2018
Q3 		$153K Sell
7,135
-2,131
-23% -$49.5K ﹤0.01% 908
2018
Q2 		$225K Sell
9,266
-815
-8% -$16.6K ﹤0.01% 785
2018
Q1 		$172K Sell
10,081
-1,477
-13% -$28.8K ﹤0.01% 884
2017
Q4 		$219K Buy
11,558
+238
+2% +$3.58K ﹤0.01% 817
2017
Q3 		$200K Sell
11,320
-23,371
-67% -$526K ﹤0.01% 844
2017
Q2 		$1.15M Sell
34,691
-1,246
-3% -$38.6K 0.01% 405
2017
Q1 		$1.15M Sell
35,937
-11,387
-24% -$389K 0.01% 468
2016
Q4 		$1.72M Buy
47,324
+2,205
+5% +$88K 0.02% 343
2016
Q3 		$2.08M Sell
45,119
-3,744
-8% -$195K 0.03% 277
2016
Q2 		$2.45M Sell
48,863
-140
-0.3% -$7.45K 0.03% 236
2016
Q1 		$2.62M Buy
49,003
+17,461
+55% +$1.02M 0.03% 235
2015
Q4 		$2.07M Sell
31,542
-3,430
-10% -$212K 0.03% 297
2015
Q3 		$1.97M Sell
34,972
-879
-2% -$57K 0.03% 312
2015
Q2 		$2.12M Buy
35,851
+1,243
+4% +$76.7K 0.03% 311
2015
Q1 		$2.16M Buy
34,608
+7,017
+25% +$408K 0.03% 300
2014
Q4 		$1.59M Sell
27,591
-53,153
-66% -$2.96M 0.02% 387
2014
Q3 		$4.34M Sell
80,744
-3,272
-4% -$173K 0.05% 202
2014
Q2 		$4.4M Sell
84,016
-6,938
-8% -$355K 0.05% 208
2014
Q1 		$4.81M Sell
90,954
-5,989
-6% -$277K 0.06% 186
2013
Q4 		$3.89M Sell
96,943
-8,751
-8% -$345K 0.05% 219
2013
Q3 		$3.99M Sell
105,694
-8,822
-8% -$344K 0.05% 207
2013
Q2 		$4.49M Buy
+114,516
New +$4.46M 0.06% 187

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Regions Financial Corp's TEVA Position: Q1 2024 in Review

Regions Financial Corp sold out of Teva Pharmaceuticals (TEVA) in Q1 2024, closing a stake of 12,394 shares — an estimated $129K sold.

Regions Financial Corp first reported a position in TEVA in Q2 2013 and held it in 25 quarters. The position peaked at $4.81M in Q1 2014. 481 funds tracked by Wall St. Rank hold TEVA as of Q1 2024.

  • Regions Financial Corp reported no remaining Teva Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Regions Financial Corp sold 12,394 Teva Pharmaceuticals shares in Q1 2024, an estimated $129K.
  • Regions Financial Corp first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 25 quarters.
  • Regions Financial Corp's Teva Pharmaceuticals position peaked at $4.81M in Q1 2014.
  • 481 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2024.

Based on Regions Financial Corp's 13F filing for Q1 2024, filed 23 Apr 2024.